Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
International Journal of Technology Assessment in Health Care|January 18, 2020
Closing the cycle of innovation in healthcare in EuropeFrank Hulstaert, Alric Ruether, Jacques Demotes, et al.Nordic Journal of Psychiatry|December 1, 2005
Venlafaxine and asthmaØyvind Melien, Tone Skaali, Kirsten Myhr, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 6, 2013
[Drugs that may trigger or exacerbate myasthenia gravis]Ahmed Elsais, Trine Haug Popperud, Øyvind Melien, et al.Public Health Genomics|August 29, 2015
Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized MedicineLada Leyens, Étienne Richer, Øyvind Melien, et al.Acta Paediatrica (Oslo, Norway : 1992)|August 30, 2006
The G protein beta3 subunit 825C allele is associated with sudden infant death due to infectionSiri Hauge Opdal, Øyvind Melien, Helge Rootwelt, et al.BMC Medical Genetics|March 6, 2014
Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 studyAnne Stine Kvehaugen, Øyvind Melien, Oddgeir L Holmen, et al.Pregnancy Hypertension|June 25, 2015
PP084. Hypertension after preeclampsia in women with C1114G polymorphism in rgs2 (the regulator of g protein signaling 2)Anne Stine Kvehaugen, Øyvind Melien, Oddgeir Lingaas Holmen, et al.International Journal of Technology Assessment in Health Care|October 28, 2020
On the integration of early health technology assessment in the innovation process: reflections from five stakeholdersMarcia Tummers, Kari Kværner, Laura Sampietro-Colom, et al.Biomed Research International|April 17, 2023
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications"Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.Biomed Research International|October 22, 2021
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and ImplicationsBrian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.Pageof 2